Chronic Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity Decreases Hypertension, Insulin Resistance, and Hypertriglyceridemia in Metabolic Syndrome

Metabolic syndrome is a constellation of risk factors including hypertension, dyslipidemia, insulin resistance, and obesity that promote the development of cardiovascular disease. Metabolic syndrome has been associated with changes in the secretion or metabolism of glucocorticoids, which have import...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnackenberg, Christine G., Costell, Melissa H., Krosky, Daniel J., Cui, Jianqi, Wu, Charlene W., Hong, Victor S., Harpel, Mark R., Willette, Robert N., Yue, Tian-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613092/
https://www.ncbi.nlm.nih.gov/pubmed/23586038
http://dx.doi.org/10.1155/2013/427640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613092/
https://www.ncbi.nlm.nih.gov/pubmed/23586038
http://dx.doi.org/10.1155/2013/427640

Ejemplares similares